## Abstract The original article to which this Erratum refers was published in Journal of Labelled Compounds and Radiopharmaceuticals 45 (10) 2002, 803–811.
Efficient synthesis and formulation of (R)-(−)-[11C]Deprenyl, a selective radioligand for the quantification of MAO-B activity using PET
✍ Scribed by Frédéric Dolle; Yann Bramoulle; Françoise Hinnen; Joanna S. Fowler
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 107 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.604
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Carbon‐11 labeled (R)‐(−)‐Deprenyl is the tracer of reference for the quantification of monoamine oxidase (MAO)‐B activity with PET. In this paper, its radiosynthesis is re‐investigated and oriented towards the preparation of multi‐milliCuries of radiotracer. Typically, using no‐carrier‐added [^11^C]methyl triflate as the alkylating agent, 140–190 mCi (5.1–7.0 GBq) of (R)‐(−)‐[^11^C]Deprenyl was obtained within 30 min of radiosynthesis (including HPLC purification and formulation) with specific radioactivities ranging from 0.8 to 1.2 Ci/μmol (29.6–44.4 GBq/μmol). The high efficiency of these radiosyntheses allows for multi‐injection protocols and kinetic approaches for absolute quantification of the tracer. Copyright © 2002 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Carbon‐11 labelled befloxatone ((5R)‐5‐(methoxymethyl)‐3‐[4‐[(3R)‐4,4,4‐trifluoro‐3‐hydroxybutoxy]phenyl]‐2‐oxazolidinone) is a reversible and selective monoamine oxidase‐A (MAO‐A) inhibitor and appears to be a new potent PET tracer for the __in vivo__ imaging of MAO‐A density. In this